Instalab

Glycyphagus Domesticus (Gly d 2) IgE Test Blood

Pinpoint whether storage mites are driving your stuck asthma or year-round congestion, beyond what standard dust mite tests reveal.

Should you take a Glycyphagus Domesticus (Gly d 2) IgE test?

This test is most useful if any of these apply to you.

Living With Stubborn Asthma or Rhinitis
If your symptoms persist despite standard dust mite avoidance and treatment, this test checks whether storage mites are the missing piece.
Working With Grain, Hay, or Animal Feed
Farmers and grain handlers face real storage mite exposure. This test checks whether your workplace is driving your respiratory symptoms.
Living in a Damp or Humid Home
Storage mites thrive where humidity is high. If your indoor environment is damp, this test can reveal whether mites are part of your allergy picture.
Building a Precise Allergy Profile
If you want a detailed map of your mite sensitization before starting immunotherapy, this component test sharpens what standard panels can show.

About Glycyphagus Domesticus (Gly d 2) IgE

If your asthma or year-round stuffy nose has not responded to the usual dust mite avoidance and treatment, your standard allergy panel may have missed the actual culprit. House dust mites are the famous indoor allergen, but storage mites like Glycyphagus domesticus thrive in damp houses, stored grain, hay, flour, and animal feed, and they trigger their own distinct allergic response in many people.

Gly d 2 IgE measures whether your immune system has built up a specific antibody response to a major protein from this storage mite. A positive result tells you that this particular allergen is part of your allergic picture, which can change what you avoid, where you focus environmental controls, and which allergens go into any immunotherapy plan.

What This Test Actually Measures

Your blood is checked for IgE (immunoglobulin E), the antibody class your immune system uses for allergic reactions. The test looks specifically for IgE that recognizes Gly d 2, a group 2 protein from Glycyphagus domesticus. Group 2 proteins are dominant trigger molecules across many storage and dust mite species, which is why this single component reveals so much about your overall mite picture.

When you breathe in mite particles repeatedly, certain immune cells (called class-switched B cells) start producing IgE antibodies tailored to specific mite proteins. The presence of Gly d 2 IgE means your body has built and stored this allergic memory. It does not by itself prove you have symptoms, but in someone with respiratory complaints it points to a specific, treatable exposure.

Why Storage Mites Deserve Their Own Test

House dust mites (the Dermatophagoides species you see on most allergy panels) and storage mites belong to different families and behave differently. Storage mites prefer damp, humid spaces and tolerate stored organic matter that house dust mites cannot. Cross-reactivity between Dermatophagoides pteronyssinus and Glycyphagus domesticus is limited, meaning a positive house dust mite test does not necessarily catch storage mite sensitization, and a negative one does not rule it out.

Among glycyphagid storage mites, cross-reactivity at the group 2 level is high. Nearly all people with IgE to Gly d 2 also react to Lep d 2 (the equivalent protein from Lepidoglyphus destructor, another common storage mite). So a positive Gly d 2 result effectively flags a broader storage mite reactivity pattern, not just one species.

Who Tends to Test Positive

Sensitization to Gly d 2 is most common in three groups: people with moderate-to-severe allergic asthma, people occupationally exposed to grain, hay, or animal feed, and people living in humid or damp homes where storage mites can thrive.

Who Was StudiedWhat Was ComparedWhat They Found
164 adults with moderate-to-severe Type-2 asthma in a humid regionHow often each storage mite component triggered IgEAbout 69 out of 100 had IgE to Gly d 2, and roughly 83 out of 100 had IgE to the related Lep d 2 protein
440 farmers screened for storage mite reactivityCombined IgE plus symptoms to four storage mites including G. domesticusAbout 12 in 100 farmers tested had storage mite allergy, working out to roughly 6 in 100 of the whole farming population
139 grain elevator workersIgE sensitization and respiratory symptoms to storage mitesRoughly 16 in 100 were sensitized to storage mites and about 6 in 100 had respiratory storage mite allergy

Sources: González-Pérez et al. 2022; Hage-Hamsten et al. 1985; Revsbech and Andersen 1987.

What this means for you: if you fit any of these profiles, especially if your allergies have not been fully explained by house dust mite testing alone, Gly d 2 IgE can fill in a meaningful gap.

Asthma and Respiratory Allergy

In people with moderate-to-severe asthma driven by a Type-2 immune pattern (the inflammatory profile behind most allergic asthma), Gly d 2 IgE was one of the most commonly recognized mite components. This matters because storage mite sensitization can drive symptoms that look like ordinary house dust mite asthma, but the avoidance strategy and immunotherapy mix should differ if storage mites are the real driver.

In a Spanish population of mite-allergic patients, Glycyphagus domesticus was present in roughly half of homes, and about half of those exposed were sensitized. The same work showed that storage mites can act as the primary sensitizer, independent of any house dust mite reaction. That is the key insight: this is not always a sidekick allergen tagging along with house dust mite allergy. For some people, it is the lead actor.

Occupational and Environmental Exposure

If you work with grain, hay, animal feed, or stored foods, or if you live in a damp home, storage mites are a real occupational and indoor hazard. Studies of farmers and grain elevator workers consistently find higher rates of storage mite IgE and respiratory symptoms than in the general population. For someone in these settings with chronic cough, wheeze, or rhinitis, testing Gly d 2 IgE alongside standard mite panels can clarify whether the workplace itself is contributing.

Why a Single Reading Is Not the Whole Story

Allergen-specific IgE levels are not static. Controlled exposure studies show that recent contact with an allergen can push specific IgE up by 40 to 60 percent or more over several weeks. That means a single number reflects both your underlying sensitization and how much you have been exposed lately. Tracking the trend over time, especially before and after environmental changes or immunotherapy, tells you more than any single result.

If you are using this test to guide changes (moving out of a damp home, removing carpets, starting immunotherapy), get a baseline now, retest in 6 to 12 months after the change, and continue at least annual monitoring if you remain symptomatic. A trend matters more than a single tier or number.

When Results Can Be Misleading

  • Recent heavy exposure: spending time around stored grain, hay, or damp dust in the weeks before your blood draw can transiently raise specific IgE, so the level captures both your baseline and your recent environment.
  • Omalizumab (an anti-IgE biologic): subcutaneous omalizumab causes a large rise in total IgE measurements through drug-antibody complexes, which can complicate interpretation of allergy panels overall, even though it does not raise specific IgE in the same way.
  • Dupilumab (an IL-4 and IL-13 blocker): treatment lowered total and specific IgE by roughly 46 to 49 percent in studied populations, so results during therapy may underestimate your baseline allergic profile.
  • Cross-reactivity within storage mites: a positive Gly d 2 result almost always travels with reactivity to Lep d 2 from a related storage mite, so do not interpret a positive as exposure to Glycyphagus alone.

What to Do With an Unexpected Result

A positive Gly d 2 result is most actionable when paired with related tests and a clear clinical picture. Order it alongside house dust mite components (such as Der p 1, Der p 2, and Der p 23) and other storage mite components (Lep d 2, Tyr p 2) to map your full mite profile. If you have asthma, a CBC with differential can flag eosinophilia, and total IgE provides additional context for biologic therapy planning.

If you are positive and symptomatic, an allergist or immunologist can help interpret the pattern, advise on targeted environmental controls (humidity below 50 percent, removing damp soft furnishings, replacing infested stored food), and assess whether allergen-specific immunotherapy that includes storage mite extracts is appropriate. A positive test in someone without symptoms generally does not warrant treatment, but it is worth retesting if symptoms develop later.

What Moves This Biomarker

Evidence-backed interventions that affect your Glycyphagus Domesticus (Gly d 2) IgE level

Decrease
Dupilumab (a biologic that blocks IL-4 and IL-13 signaling)
Dupilumab is used for atopic dermatitis, asthma, and related Type-2 conditions, and as a side effect it lowers allergen-specific IgE substantially. In a study of 22 adults with atopic dermatitis, specific IgE to various allergens fell by roughly 46 to 49 percent during treatment, while protective IgG4 rose. If you are on dupilumab, your Gly d 2 IgE result may understate your true baseline sensitization, which matters if you stop the drug and want to know your underlying allergy profile.
MedicationStrong Evidence
Up & Down
Allergen-specific immunotherapy with house dust mite or storage mite extracts
If you have confirmed mite allergy, immunotherapy retrains your immune system over months to years, with specific IgE often rising briefly in the first phase and then stabilizing or declining as protective IgG4 antibodies rise. In a study of patients on house dust mite immunotherapy, specific IgE and IgG4 patterns shifted measurably during treatment, and across multiple trials this rebalancing tracks with reduced asthma and rhinitis symptoms. The effect on Gly d 2 specifically has not been measured directly in these trials.
MedicationModerate Evidence
Increase
Occupational exposure to grain, hay, or animal feed
Working in grain handling, farming, or animal feed environments raises the rate of storage mite IgE and respiratory symptoms. Grain elevator workers showed roughly 16 in 100 sensitized to storage mites and about 6 in 100 with respiratory storage mite allergy, with Gly d 2 among the panel tested. Persistent occupational exposure drives ongoing sensitization, which is reflected in higher specific IgE and more symptoms over time.
LifestyleModerate Evidence
Decrease
Reduce home humidity and storage mite habitat
Storage mites thrive in damp environments and infested stored foods. Cutting indoor humidity below 50 percent, removing damp soft furnishings, and discarding mite-infested grain or flour reduces ongoing exposure, which over months can blunt the recurrent IgE boosts that come with continued contact. Direct measurement of Gly d 2 IgE after environmental change has not been published, but controlled exposure studies show that recent allergen contact alone can raise specific IgE by 40 to 60 percent, implying that removing exposure should reduce these spikes.
LifestyleModest Evidence

Frequently Asked Questions

References

9 studies
  1. Hage-hamsten M, Johansson S, Höglund S, Tüll P, Wirén a, Zetterstrom OClinical & Experimental Allergy1985
  2. Revsbech P, Andersen GAllergy1987
  3. Arias-irigoyen J, Lombardero M, Arteaga C, Carpizo J, Barber DThe Journal of Allergy and Clinical Immunology2007
  4. González-pérez R, Poza-guedes P, Pineda F, Castillo M, Sánchez-machín IInternational Journal of Molecular Sciences2022
  5. Egger C, Lupinek C, Ristl R, Lemell P, Horak F, Zieglmayer P, Spitzauer S, Valenta R, Niederberger VPLoS ONE2015